Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Investigation into the origin and tumoral mass correlation of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma.

× No keyword cloud information.

10 in total

1. Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma.

Authors: Fei-Peng Zhao; Xiong Liu; Xiao-Mei Chen; Juan Lu; Bo-Long Yu; Wen-Dong Tian; L U Wang; Xia Xu; Hao-Ran Huang; Meng-Wen Zhang; Gang Li; Xiang-Ping Li
Journal: Oncol Lett Date: 2015-08-24 Impact factor: 2.967

Review 2. Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers.

Authors: K C A Chan; Y M D Lo
Journal: Br J Cancer Date: 2007-02-20 Impact factor: 7.640

3. Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma.

Authors: K C Allen Chan
Journal: Chin J Cancer Date: 2014-11-21

4. Interplay of Tumor Spread, Volume and Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: Feasibility of An Integrative Risk Stratification Scheme.

Authors: Xin Zhou; Youqi Yang; Xiaomin Ou; Tingting Xu; Chunying Shen; Chaosu Hu
Journal: J Cancer Date: 2018-10-20 Impact factor: 4.207

Review 5. Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker.

Authors: Wai Kei Jacky Lam; Kwan Chee Allen Chan; Yuk Ming Dennis Lo
Journal: J Pathol Date: 2019-02-25 Impact factor: 7.996

6. Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).

Authors: Brigette B Y Ma; Wan-Teck Lim; Boon-Cher Goh; Edwin P Hui; Kwok-Wai Lo; Adam Pettinger; Nathan R Foster; Jonathan W Riess; Mark Agulnik; Alex Y C Chang; Akhil Chopra; Julie A Kish; Christine H Chung; Douglas R Adkins; Kevin J Cullen; Barbara J Gitlitz; Dean W Lim; Ka-Fai To; K C Allen Chan; Y M Dennis Lo; Ann D King; Charles Erlichman; Jun Yin; Brian A Costello; Anthony T C Chan
Journal: J Clin Oncol Date: 2018-03-27 Impact factor: 50.717

7. Positivity of both plasma Epstein-Barr virus DNA and serum Epstein-Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma.

Authors: Fei-Peng Zhao; Xiong Liu; Zhi-Ming Zhong; Juan Lu; Bo-Long Yu; Fang-Yin Zeng; Xiao-Mei Chen; Huai-Hong Chen; Xiao-Hong Peng; Fan Wang; Ying Peng; Xiang-Ping Li
Journal: BBA Clin Date: 2014-10-31

8. Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.

Authors: W K Jacky Lam; Peiyong Jiang; K C Allen Chan; Suk H Cheng; Haiqiang Zhang; Wenlei Peng; O Y Olivia Tse; Yu K Tong; Wanxia Gai; Benny C Y Zee; Brigette B Y Ma; Edwin P Hui; Anthony T C Chan; John K S Woo; Rossa W K Chiu; Y M Dennis Lo
Journal: Proc Natl Acad Sci U S A Date: 2018-05-14 Impact factor: 11.205

9. Relationship between pretreatment concentration of plasma Epstein-Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation.

Authors: Liang Peng; Yi Yang; Rui Guo; Yan-Ping Mao; Cheng Xu; Yu-Pei Chen; Ying Sun; Jun Ma; Ling-Long Tang
Journal: Cancer Med Date: 2018-10-30 Impact factor: 4.452

10. Prognostic value of hepatitis B viral infection in patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.

Authors: Shuo-Han Zheng; Shu Zhou; Guan-Nan Wang; Zi-Lu Huang; Song-Ran Liu; Chen Chen; Ya-Lan Tao; Hui Chang; Shi-Rong Ding; Ruo-Nan Liao; Chang Chen; Yun-Fei Xia
Journal: Transl Cancer Res Date: 2021-11 Impact factor: 1.241

10 in total